Patents by Inventor Klaus Andreas DUGI

Klaus Andreas DUGI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC USES OF UROLITHIN DERIVATIVES
    Publication number: 20240139149
    Abstract: Disclosed are methods for treating a neuromuscular disorder, muscle disorder, heart disease, pulmonary fibrosis, liver disease, inflammatory bowel disease, or cancer. Also disclosed is a method of enhancing cancer immunotherapy.
    Type: Application
    Filed: July 26, 2023
    Publication date: May 2, 2024
    Inventors: Penelope Andreux, Klaus Andreas Dugi, Christopher L. Rinsch, Florian Greten, Dominic Denk
  • COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20170189437
    Abstract: The present invention is directed to a pharmaceutical composition comprised of one or more SGLT-2 inhibitor compound(s) in combination with one or more therapeutic agents which is suitable for the treatment of metabolic disorders including type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance, hyperglycemia, postprandial hyperglycemia, overweight, obesity, including class I obesity, class II obesity, class III obesity, visceral obesity and abdominal obesity, and metabolic syndrome.
    Type: Application
    Filed: March 22, 2017
    Publication date: July 6, 2017
    Inventors: Alireza Monshizadeh MANUCHEHRI, Klaus Andreas DUGI, Peter EICKELMANN, Leo THOMAS